Year of investment: 2008
Isobionics is a company that uses a proprietary biotechnology process for the production of flavor and fragrance ingredients. Its focus is on isoprenoid-based products for food, beverage, flavor and fragrance markets. The biotechnology process delivers products with higher quality and purity, at lower production cost.
Year of investment: 2008
Chemtrix BV supplies complete and customized microreactor systems for R&D and commercial manufacturing. Chemtrix’ microreactors enhance process efficiency, energy efficiency and safety of chemical synthesis in the fine chemical and pharmaceutical industries.
Year of investment: 2007
PharmaCell is world leader in cell-culturing services using its GMP-certified manufacturing facilities in Maastricht and Geleen. Its customers include the world leaders in commercial cell therapy products. Pharmacell has access to an extensive network which gives it the capability to provide support and/or partnership to R&D companies to bring new products from the lab into the clinic.
Year of investment: 2006
Oxford Performance Materials supplies its versatile OXPEKK® polymers to space and defense, medical, semiconductor, and industrial markets worldwide. The company was sold to Arkema in early 2009.
Year of investment: 2006
Polyscope Polymers is a supplier of SMA copolymers for the automotive, paper and construction industries. Its engineering plastics compounds are sold primarily to the automotive industry for e.g. instrument panels and roof frames. Its low molecular grades, low and high MA content grades, liquid forms and imidized products find applications in many specialty markets. The company is based at the Chemelot site where it also has its production assets.
Year of investment: 2004
In 2009 the company was part of a transaction involving an MBI and which provided a partial exit for shareholders.
The assets were transferred to Fortimedix Holding BV.